RecruitingPhase 2NCT03866382
Oncology
Collecting duct carcinoma
5
studies recruiting now
as of 7 Sept 2026
19
studies registered in total
as of 7 Sept 2026
10
countries with a recruiting site
as of 7 Sept 2026
9 Dec 2024
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT06675604
LEOPARD Training and Validation Data Collection Study
RecruitingNCT06723275
LEOPARD Prospective Validation Cohort 1
RecruitingPhase 2NCT06302569
Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma
RecruitingPhase 2NCT06211114
Study to Evaluate the Efficacy and Safety of Immunotherapy With Axitinib in Advanced Collecting Duct Carcinoma
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Collecting duct carcinoma studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Collecting duct carcinoma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Collecting duct carcinoma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
4 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 2Pembrolizumab (Keytruda)
Phase 2Bevacizumab (Abevmy)
Phase 2Cabozantinib
Phase 2Axitinib (Inlyta)
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).